DK152058B - Fremgangsmaade til fremstilling af et insulinsekretionsfremmende stof - Google Patents
Fremgangsmaade til fremstilling af et insulinsekretionsfremmende stof Download PDFInfo
- Publication number
- DK152058B DK152058B DK045378AA DK45378A DK152058B DK 152058 B DK152058 B DK 152058B DK 045378A A DK045378A A DK 045378AA DK 45378 A DK45378 A DK 45378A DK 152058 B DK152058 B DK 152058B
- Authority
- DK
- Denmark
- Prior art keywords
- administration
- glucose
- iap
- insulin
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1039777 | 1977-02-01 | ||
| JP1039777A JPS5396392A (en) | 1977-02-01 | 1977-02-01 | Active substance for increasing secretion of insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK45378A DK45378A (da) | 1978-08-02 |
| DK152058B true DK152058B (da) | 1988-01-25 |
Family
ID=11748989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK045378AA DK152058B (da) | 1977-02-01 | 1978-01-31 | Fremgangsmaade til fremstilling af et insulinsekretionsfremmende stof |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5000953A (ja) |
| JP (1) | JPS5396392A (ja) |
| AU (1) | AU513963B2 (ja) |
| BE (1) | BE863477A (ja) |
| CA (1) | CA1105863A (ja) |
| CH (1) | CH640244A5 (ja) |
| CS (1) | CS216547B2 (ja) |
| DE (1) | DE2803397A1 (ja) |
| DK (1) | DK152058B (ja) |
| ES (1) | ES467067A1 (ja) |
| FR (1) | FR2378793A1 (ja) |
| GB (1) | GB1569046A (ja) |
| HU (1) | HU179497B (ja) |
| IE (1) | IE46649B1 (ja) |
| NL (1) | NL7801137A (ja) |
| NZ (1) | NZ186361A (ja) |
| SE (1) | SE7801106L (ja) |
| SU (1) | SU871721A3 (ja) |
| ZA (1) | ZA7855B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59206316A (ja) * | 1983-05-11 | 1984-11-22 | Kaken Pharmaceut Co Ltd | インシユリン分泌増強活性物質誘導体およびその製法 |
| US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
| US6143786A (en) * | 1999-02-02 | 2000-11-07 | Novartis Nutrition Ag | Oral arginine and insulin secretion |
| WO2001085256A2 (en) * | 2000-05-05 | 2001-11-15 | Novo Nordisk A/S | Critical illness neuropathy |
| US6986882B2 (en) * | 2002-01-17 | 2006-01-17 | Astrazeneca Ab | Therapy for functional dyspepsia |
| US20030199445A1 (en) * | 2002-02-07 | 2003-10-23 | Knudsen Lotte Bjerre | Use of GLP-1 compound for treatment of critically ill patients |
-
1977
- 1977-02-01 JP JP1039777A patent/JPS5396392A/ja active Granted
-
1978
- 1978-01-05 ZA ZA00780055A patent/ZA7855B/xx unknown
- 1978-01-26 DE DE19782803397 patent/DE2803397A1/de active Granted
- 1978-01-30 FR FR7802479A patent/FR2378793A1/fr active Granted
- 1978-01-30 CS CS78623A patent/CS216547B2/cs unknown
- 1978-01-30 BE BE6046338A patent/BE863477A/xx not_active IP Right Cessation
- 1978-01-30 SE SE7801106A patent/SE7801106L/xx unknown
- 1978-01-31 CH CH101578A patent/CH640244A5/de not_active IP Right Cessation
- 1978-01-31 DK DK045378AA patent/DK152058B/da not_active Application Discontinuation
- 1978-01-31 GB GB3881/78A patent/GB1569046A/en not_active Expired
- 1978-01-31 CA CA295,971A patent/CA1105863A/en not_active Expired
- 1978-01-31 IE IE205/78A patent/IE46649B1/en unknown
- 1978-01-31 HU HU78KA1500A patent/HU179497B/hu unknown
- 1978-01-31 AU AU32854/78A patent/AU513963B2/en not_active Expired
- 1978-01-31 NZ NZ186361A patent/NZ186361A/xx unknown
- 1978-01-31 SU SU782576599A patent/SU871721A3/ru active
- 1978-02-01 NL NL7801137A patent/NL7801137A/xx not_active Application Discontinuation
- 1978-02-01 ES ES467067A patent/ES467067A1/es not_active Expired
-
1989
- 1989-03-23 US US07/327,382 patent/US5000953A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IE780205L (en) | 1978-08-01 |
| DK45378A (da) | 1978-08-02 |
| GB1569046A (en) | 1980-06-11 |
| US5000953A (en) | 1991-03-19 |
| JPS5396392A (en) | 1978-08-23 |
| AU3285478A (en) | 1979-08-09 |
| FR2378793A1 (fr) | 1978-08-25 |
| DE2803397A1 (de) | 1978-08-03 |
| DE2803397C2 (ja) | 1990-01-25 |
| BE863477A (fr) | 1978-07-31 |
| CA1105863A (en) | 1981-07-28 |
| NL7801137A (nl) | 1978-08-03 |
| CS216547B2 (en) | 1982-11-26 |
| ES467067A1 (es) | 1978-11-01 |
| IE46649B1 (en) | 1983-08-10 |
| SE7801106L (sv) | 1978-08-02 |
| ZA7855B (en) | 1978-11-29 |
| JPS5635154B2 (ja) | 1981-08-14 |
| FR2378793B1 (ja) | 1982-10-22 |
| SU871721A3 (ru) | 1981-10-07 |
| HU179497B (en) | 1982-10-28 |
| CH640244A5 (en) | 1983-12-30 |
| NZ186361A (en) | 1980-10-08 |
| AU513963B2 (en) | 1981-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4451455A (en) | α-Amylase inactivator, a process for its preparation, an agent based on this inactivator and its use | |
| Brange | Galenics of insulin: the physico-chemical and pharmaceutical aspects of insulin and insulin preparations | |
| JP4519324B2 (ja) | 共有結合で架橋されたインスリンダイマー | |
| KR940005793A (ko) | 정제 콘도로이티나제의 제조법 및 의약조성 | |
| WO1988007863A1 (en) | Human somatomedin carrier protein subunits and process for producing them | |
| EP0172577B1 (en) | A superoxide dismutase, its production and pharmaceutical compositions containing it | |
| CN109776652B (zh) | 鳕鱼皮寡肽及其分离纯化方法和在制备ɑ-葡萄糖苷酶抑制剂及抗Ⅱ型糖尿病药物中的应用 | |
| US4234570A (en) | Proteinic active substances | |
| DE3587526T3 (de) | Serinproteaseinhibitoren und isolierungsverfahren dazu. | |
| DK152058B (da) | Fremgangsmaade til fremstilling af et insulinsekretionsfremmende stof | |
| KR920002935B1 (ko) | 맥관 형성 저해제 | |
| US4339436A (en) | α-Amylase inhibitor from a streptomycete and process for its preparation | |
| CN110759991B (zh) | 吉非罗齐-非洲爪蟾胰高血糖素样肽-1衍生物及其应用 | |
| US4609549A (en) | Biologically active substance from Islets-Activating Protein | |
| Ågren | On the properties of secretin | |
| US5242900A (en) | Treatment of diabetes using phosphorylated insulin | |
| RU2166957C1 (ru) | Тетрапептид, стимулирующий функциональную активность гепатоцитов, фармакологическое средство на его основе и способ его применения | |
| Steele et al. | Antilipolytic effect of porcine proinsulin | |
| US3509120A (en) | N-terminal mono- and diaminoacyl-insulin | |
| EP0661293A2 (en) | Protein having cell growth-stimulating and macrophage chemotactic actions, preparative method therefor and use thereof | |
| KR820000372B1 (ko) | 인슐린 분비촉진 활성물질의 제조방법 | |
| EP0679659A1 (en) | Cathepsin-l-specific inhibitor polypeptide | |
| US5108610A (en) | Method for isolating dithiochrome, an insulin-binding molecule with glucose metabolism-related pharmaceutical utility | |
| Davidson | The effect of guanidinosuccinic acid on in-vitro carbohydrate metabolism | |
| JPS6153222A (ja) | インスリン作用増強剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PHB | Application deemed withdrawn due to non-payment or other reasons |